Financial performance
View the latest quarterly and annual financial information to keep up to date on Sun Life results.
Quarterly results
Review financial results for the most recently ended quarter and past quarters.
Annual reports
Read about our financial performance and achievements as well as our strategy for the future.
| C$ millions(1) (unless otherwise noted) |
Q3 2019 | Q2 2019 | Q3 2018 | Full Year 2018 | Full Year 2017 |
|---|---|---|---|---|---|
| Reported net income | 681 | 595 | 567 | 2,522 | 2,149 |
| Underlying net income2 | 809 | 739 | 730 | 2,947 | 2,546 |
| Diluted Report EPS ($) | 1.15 | 1.00 | 0.93 | 4.14 | 3.49 |
| Diluted Underlying EPS ($)2 | 1.37 | 1.24 | 1.20 | 4.86 | 4.15 |
| Number of common shares outstanding (in millions) |
587.6 | 591.0 | 603.3 | 598.5 | 610.5 |
| Reported ROE | 13.0% | 11.0% | 10.8% | 12.1% | 10.7% |
| Underlying ROE2 | 15.5% | 13.7% | 14.0% | 14.2% | 12.7% |
| Premiums and deposits2 | 46,495 | 43,275 | 35,462 | 160,108 | 164,680 |
| LICAT Ratio SLF3 | 146% | 144% | 145% | 144% | n/a |
| Dividend per share | 0.525 | 0.525 | 0.475 | 1.905 | 1.745 |
1 All numbers are unaudited. All numbers are in Canadian dollar millions, unless otherwise noted.
2 Underlying net income (loss), underlying earnings (loss) per share, underlying ROE and premiums and deposits are non-IFRS financial measures. Additional information concerning these non-IFRS financial measures and reconciliations to the closest IFRS measures are available in section M - Non-IFRS Financial Measures of the Earnings News Release. All EPS measures refer to diluted EPS, unless otherwise stated.
3 Life Insurance Capital Adequacy Test (“LICAT”) ratio. LICAT ratios are not applicable before January 1, 2018; we previously used the Minimum Continuing Capital and Surplus Requirements (“MCCSR”) guideline, the former capital regulatory guideline.